ARJO-BArjo AB (publ)
24.84SEK+0.49%Mkt Cap: 6.79B SEKP/E: 19.32Last update: 2026-05-13

Arjo AB (publ) develops and sells medical devices and solutions for patients for clinical and financial outcomes for healthcare in Europe, Asia, Latin America, Africa, and the Pacific. It offers products and solutions fo…

loading…
Indicators:|

Key Statistics

Valuation
P/E (Trailing)19.32
P/E (Forward)9.30
PEG
P/B0.87
P/S0.63
EV/EBITDA7.79
EV/Revenue1.04
EPS (TTM)1.29
EPS (Forward)2.68
Cash Flow & Leverage
FCF Yield13.94%
FCF Margin8.73%
Operating CF1.44B SEK
CapEx (TTM)708.00M SEK
Net Debt/EBITDA3.10
Net Debt4.48B SEK
Technical
SMA 5025.36 (-2.1%)
SMA 20029.65 (-16.2%)
Beta0.66
S&P 52W Chg24.23%
Avg Vol (30d)439.67K
Avg Vol (10d)330.62K
Technical Indicators
RSI (14)44.2
MACD-0.2788
MACD Signal-0.2795
MACD Hist.+0.0007
BB Upper27.48 SEK
BB Middle25.40 SEK
BB Lower23.32 SEK
BB Width16.38%
ATR (14)0.5529 SEK
Vol Ratio (20d)0.29x
52W Range
24.026% of range36.94
52W High36.94 SEK
52W Low24.02 SEK
Profitability
Gross Margin42.59%
EBITDA Margin13.35%
Profit Margin3.04%
Oper. Margin7.08%
ROE4.48%
ROA2.23%
Revenue Growth-5.80%
Earnings Growth18.70%
Balance Sheet
Debt/Equity0.72
Current Ratio1.08
Quick Ratio0.76
Book Value/Sh28.69 SEK
Cash/Share3.297 SEK
Dividends
Fwd Div Rate0.9500 SEK
Trail. Div Rate0.9500 SEK
Div. Yield3.81%
5Y Avg Yield2.18%
Payout Ratio73.64%
Ex-Div DateApr 23, 2026
Pay Date
Ownership
Shares Out.254.15M
Float185.08M
Insiders24.72%
Institutions41.41%
Analyst Consensus
Rating
Target (Mean)30.00 SEK
Target Range27.00 SEK33.00 SEK
# Analysts5
Company
Market Cap6.79B SEK
Enterprise Value11.27B SEK
Revenue (TTM)10.84B SEK
Gross Profit4.68B SEK
Net Income (TTM)334.00M SEK
Revenue/Share39.78 SEK
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees7.0K
Last Price24.84 SEK
CountrySE
SectorHealthcare
IndustryMedical Distribution
ISIN